S. Debarbieux
Hospices Civils de Lyon(FR)Hôpital Lyon Sud(FR)
Publications by Year
Research Areas
Cutaneous Melanoma Detection and Management, Autoimmune Bullous Skin Diseases, Cutaneous lymphoproliferative disorders research, Nonmelanoma Skin Cancer Studies, Urticaria and Related Conditions
Most-Cited Works
- → First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial(2017)587 cited
- → Dermoscopy of lentigo maligna melanoma: report of 125 cases(2012)160 cited
- → Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection(2007)96 cited
- → Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid‐sparing effect(2019)91 cited
- → Calculation of cut‐off values based on the Autoimmune Bullous Skin Disorder Intensity Score ( ABSIS ) and Pemphigus Disease Area Index ( PDAI ) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus(2016)90 cited
- → Large International Validation of ABSIS and PDAI Pemphigus Severity Scores(2018)89 cited